Clinical Screening: Multimodal Voice Biomarkers vs. Tablet-Based Testing
Two approaches to cognitive assessment in clinical settings. Different modalities, different workflows.
BrainCheck provides tablet-based neurocognitive testing for primary care, neurology, and senior living facilities. Patients interact with digital tasks on a tablet, and results are scored automatically. GIA® by Scienza Health screens for 46 conditions across cognitive, behavioral, and neurological categories using voice biomarkers and computer vision in a single conversation. Both tools aim to make cognitive assessment more accessible. The differences are in modality, condition coverage, and operational model.
How do they compare?
| Dimension | BrainCheck | GIA™ |
|---|---|---|
| Patient interaction | Digital tasks on tablet | Natural conversation (video, voice, or landline) |
| Condition categories | Cognitive assessment | Cognitive, behavioral, and neurological (46 conditions) |
| Screening time | 10-15 minutes | Under 5 minutes |
| Staff required | Check vendor documentation | Zero during screening |
| Modality | Tablet-based neurocognitive tests | Voice AI + Computer Vision + Speech Biomarkers |
| Regulatory status | Check vendor documentation | 510(k) cleared |
Where braincheck falls short
A digital cognitive assessment platform using tablet-based neurocognitive testing. Targets primary care, neurology, and senior living. Patients complete digital cognitive tasks on a tablet device.
- Tablet-based testing requires patient interaction with a digital interface
- Assessment time is 10 to 15 minutes per patient
- Focuses on cognitive assessment domains
- Check vendor documentation for condition coverage and regulatory status
What GIA™ does differently
- 46 conditions across cognitive, behavioral, and neurological categories
- Under 5 minutes per screening. Results in 60 seconds
- Voice-based: requires only natural conversation, no device interaction by patient
- Zero clinical staff required during screening
- 2,500+ speech biomarkers analyzed alongside computer vision
- 510(k) cleared. 19 peer-reviewed studies from Beth Israel, NIH, and MIT
- Results prepared for clinician review and submission to the EHR
BrainCheck digitizes cognitive testing through tablet-based tasks. GIA® by Scienza Health screens through natural conversation using voice biomarkers and computer vision. For facilities where patients have difficulty interacting with digital interfaces or where staffing prevents one-on-one test administration, voice-based screening removes both barriers. The clinician always reviews and decides.
Common questions
Which approach works better for patients with cognitive impairment?
Tablet-based testing requires patients to understand and interact with a digital interface, which can be difficult for patients with moderate cognitive impairment. GIA® by Scienza Health uses natural conversation. The patient speaks normally. No device interaction required. Voice biomarkers capture clinical signals from 40 seconds of speech without the patient needing to perform tasks.
Can GIA® screen for conditions beyond cognitive impairment?
Yes. GIA® by Scienza Health screens across cognitive, behavioral, and neurological categories in one conversation. 46 conditions including depression, PTSD, anxiety, Parkinson’s, tardive dyskinesia, and burnout. Tablet-based cognitive tests typically assess cognitive domains only. Behavioral and neurological screening requires separate instruments.
How does the clinical review process work with GIA®?
After each screening, GIA® by Scienza Health prepares structured medical notes, CPT codes, biomarker results, and session video for the clinician. The clinician reviews the complete package in under two minutes and decides what action to take. Nothing enters the clinical record without clinician authorization. 510(k) cleared.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.